United States

ENDO 2021

Using the Available Evidence to Personalize Osteoporosis Treatment

Welcome to **ENDO** - the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

**Endocrine Society** is a global community of physicians and scientists dedicated to accelerating scientific breakthroughs and improving patient health and well being.
<br><br>
For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. **[Read about our history](https://www.endocrine.org/our-community/advancing-endocrinology-and-public-health/history)** and how we continue to serve the endocrine community.

ENDO 2020

ENDO is the place where leading experts, researchers, and the most respected clinicians in the field come together to share the latest findings in hormone science and discuss breakthroughs in clinical care.

technical paper

Human Pancreatic Beta Cell Regeneration for Diabetes: A Journey From Impossible to Possible

Dysregulation of Lipid Metabolism: Impact on the Beta Cell in Type 2 Diabetes

Omics to Novel Pathways in the Pancreatic Islet

Ovarian Morphology From Childhood into AdulthoodRelevance to the Diagnosis of Polycystic Ovary Syndrome

Reproductive & Metabolic Phenotypes in the Peripubertal Period

Lifestyle Approaches for the Adolescent with PCOS

Genetics of Cushing's Disease

Adrenal Somatic Gene Mutations Causing Cortisol Excess

Inherited Gene Mutations Causing Primary Macronodular Adrenal Hyperplasia in Familial Cushing's Syndrome

The GnRH Neuron Pulse Generator in Vivo

https://d3smihljt9218e.cloudfront.net/transcript/25831/subtitle/99b6393566853c3e48889d835f675621.vtt

English (automatic)

Using the Available Evidence to Personalize Osteoporosis Treatment

Downloads

Next from ENDO 2021

Human Pancreatic Beta Cell Regeneration for Diabetes: A Journey From Impossible to Possible

Similar lecture

Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES